5:17 PM
 | 
Mar 24, 2014
 |  BC Extra  |  Financial News

Karyopharm planning $115 million follow-on

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) proposed to raise up to $115 million in a follow-on underwritten by BofA Merrill Lynch; Leerink Partners; JMP Securities; Wedbush PacGrow;...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >